Axogen Inc vs Capital One Financial Corp. — how do they compare? Axogen Inc trades at $48.35 (market cap $2.61B), while Capital One Financial Corp. trades at $219.37 (market cap $134.45B). The key difference: Capital One Financial Corp. is far larger — about 51.5× Axogen Inc's market cap, and Capital One Financial Corp. pays a 1.46% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | COF | |
|---|---|---|
Market Cap | $2.61B | $134.45B |
Sector | Technology | Financials |
52-Week High | $48.48 | $257.94 |
52-Week Low | $14.16 | $176.10 |
Enterprise Value | $2.52B | — |
Dividend Yield | — | 1.46% |
Signals from Pluang's Aura AI — not financial advice
AXGN is trading at $46.43, up 4.69% today, with strong technical momentum and bullish moving average signals. The company reported Q2 2026 revenue growth of 23.1% to $69.7 million and raised full-year guidance to at least $279 million. Despite recent earnings misses, analyst sentiment remains overwhelmingly positive with 84% buy ratings and a $54.33 price target.
The stock presents growth potential driven by expanding nerve care platform adoption and reimbursement improvements, but faces risks from persistent net losses (-$15.7M in 2025) and high valuation multiples (P/S 9.5). Near-term performance hinges on Q3 earnings delivery and continued commercial execution amid competitive pressures.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending.
Read more on COF →